Sugi Predict

Sugi Predict / Compounds / SCHEMBL25819001

SCHEMBL25819001

SCHEMBL25819001

CC(C)(C)c1ccc(C2CC(=O)NC(=O)C2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ BRD4 O60885 1/20 0.43
▸ CREBBP Q92793 1/20 0.43
▸ CRBN Q96SW2 2/20 0.42
▸ DDB1 Q16531 1/20 0.42
▸ TNKS2 Q9H2K2 2/20 0.41
▸ TNKS O95271 1/20 0.41
▸ PARP3 Q9Y6F1 1/20 0.41
▸ MGLL Q99685 1/20 0.38
▸ TP53 P04637 3/20 0.38
▸ GABRA1 P14867 1/20 0.38
▸ GABRG2 P18507 1/20 0.38
▸ GABRB3 P28472 1/20 0.38
▸ MAPT P10636 3/20 0.37
▸ TSHR P16473 1/20 0.37
▸ LIPE Q05469 1/20 0.37
▸ NFKB1 P19838 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10698615 0.82 KMT2A (0.47) MEN1NPC1RAB9AKMT2ATNKS2
SCHEMBL9706513 0.82 TSHR (0.56) MEN1KMT2ACREBBPMAPTTSHR
SCHEMBL3282827 0.80 ALDH2 (0.46) MEN1NPC1RAB9AKMT2ACRBN
SCHEMBL13454073 0.79 MAPT (0.57) MEN1NPC1RAB9AKMT2ATNKS2
SCHEMBL14492201 0.79 MAP1LC3B (0.50) BRD4CREBBPCRBNDDB1MAPT
SCHEMBL3035436 0.78 ALDH1A1 (0.45) MEN1NPC1RAB9AKMT2ATNKS2
SCHEMBL15158673 0.77 NPC1 (0.39) MEN1NPC1RAB9AKMT2ABRD4
SCHEMBL12326005 0.76 TNKS2 (0.46) MEN1NPC1RAB9AKMT2ABRD4
SCHEMBL1859440 0.75 CYP19A1 (0.61) CRBNDDB1MAPTTSHRCYP19A1
SCHEMBL1673541 0.75 LMNA (0.49) MEN1NPC1KMT2ABRD4CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912710-B2 Substituted pyrimido[4,5-b][1,4]diazepines as PLK1 degradation inducers UPPTHERA, INC. (KR) 2024-02-27 — — US disclosed
US-11912710-B2 Substituted pyrimido[4,5-b][1,4]diazepines as PLK1 degradation inducers UPPTHERA, INC. (KR) 2024-02-27 — — US disclosed
US-20230242541-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-08-03 — — US disclosed
US-20230242541-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-08-03 — — US disclosed
US-20230219966-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-07-13 — — US disclosed
US-20230219966-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219966-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND PLK1, BUB1B, BUB1 MEN1 3403/4885NPC1 2366/4885RAB9A 1993/4885
US-20230242541-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND PLK1, BUB1B, BUB1 MEN1 3403/4885NPC1 2366/4885RAB9A 1993/4885
US-11912710-B2 Substituted pyrimido[4,5-b][1,4]diazepines as PLK1 degradation inducers PLK1, BUB1B, BUB1 MEN1 2443/4885NPC1 2960/4885RAB9A 1887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.